DNA Testing Laboratory Operations

Interleukin Genetics has built a state-of-the-art, high throughput DNA testing laboratory that is certified under the Clinical Laboratories Improvements Act (CLIA).  Following a June 2006 expansion and upgrade, including additional equipment and staff to enable the laboratory to improve turnaround time for test results and increase efficiencies, the Interleukin Testing Laboratory is capable of handling a substantial volume of DNA risk assessment tests.  It currently offers a DNA test that identifies certain variations in the interleukin-1 (IL-1) genes that is provided to health-conscious consumers through the Quixtar organization.

                                             

The laboratory is staffed by technicians and scientists who developed substantial laboratory operations experience prior to joining Interleukin.  Patricia Murphy, Ph.D., FACMG, is the Laboratory Director.

Interleukin's DNA testing laboratory includes a Class 8 clean room and the latest robotics and analytical instruments available from a leading instrument supplier to ensure the highest accuracy in sample analysis.

The laboratory is firmly committed to the highest quality of service to its customers.  As part of that service, it adheres to strict standards of privacy.  Test results are reported only to the consumer who provided the sample (or to an individual designated on his behalf) and the designated physician.  The company destroys the sample soon after testing, and it retains test results in a manner that satisfies or exceeds all relevant regulatory standards.

 

back to top